Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.409, Iss.1, 2000-12, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats

By Zheng Dezhi Zhong Guocheng Hu Yonghe

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 9, 2013-01 ,pp. : 759-763

NRC Research Press

Access to resources Recommend Favorite

The effect of agmatine on the vascular reactivity in streptozotocin-diabetic rats

By Ozyazgan S. Bicakci B. Ozaydin A. Denizbasi A. Unluer E.E. Akkan A.G.

Pharmacological Research, Vol. 48, Iss. 2, 2003-08 ,pp. : 133-138

Elsevier

Access to resources Recommend Favorite

Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats

By Yamamoto Y. Yasuda Y. Kimura Y. Yoshiaki Komiya

European Journal of Pharmacology, Vol. 352, Iss. 2, 1998-07 ,pp. : 171-178

Elsevier

Access to resources Recommend Favorite

Prostaglandin-release impairment in the bladder epithelium of streptozotocin-induced diabetic rats

By Pinna C. Zanardo R. Puglisi L.

European Journal of Pharmacology, Vol. 388, Iss. 3, 2000-02 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite

Effects of propionyl-l-carnitine on cardiac dysfunction in streptozotocin-diabetic rats

By Terada R. Matsubara T. Koh N. Nakamura J. Hotta N.

European Journal of Pharmacology, Vol. 357, Iss. 2, 1998-09 ,pp. : 185-191

Elsevier

Access to resources Recommend Favorite